跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NR-14
首页
药物
NR-14
NR-14
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COSMETIC SUCCINIMIDE COMPOUNDS
EP 4251610 B1
申请人: TARA BRANDS EUROPE S L U
优先权: 2022
CN
EP
US
WO
5 件公开
HIV inhibiting pyrimidines derivatives
US 7125879 B2
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2001
CN
US
4 件公开
P-terphenyl compounds
US 7101915 B1
申请人: SHIONOGI & CO
优先权: 1996
US
4 件公开
Pesticidal indazole or benzotriazole derivatives
US 7112553 B1
申请人: SYNGENTA LTD
优先权: 1999
CN
US
3 件公开
Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same
US 7425564 B2
申请人: KIRIN BREWERY
优先权: 2001
CN
US
3 件公开
Substituted benzopyran derivatives against arrhythmia
US 7041700 B2
申请人: NISSAN CHEMICAL IND LTD
优先权: 2001
CN
US
3 件公开
Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
US 7294628 B2
申请人: SANOFI AVENTIS
优先权: 2002
US
3 件公开
Heterocyclic compounds and thrombopoietin receptor activators
US 7351841 B2
申请人: NISSAN CHEMICAL IND LTD
优先权: 2003
US
3 件公开
Mikanolide derivatives, their preparation and therapeutic uses
US 6887869 B2
申请人: SOD CONSEILS RECH APPLIC
优先权: 2001
CN
US
2 件公开
Chemical Compounds
US 2007219232 A1
申请人: GLAXO GROUP LTD
优先权: 2001
CN
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈